+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032- Product Image
Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032- Product Image
New

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904519
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Helicobacter pylori non-invasive testing market is moving through a technology-focused evolution, presenting decision-makers with a complex yet dynamic landscape shaped by the need for patient-centered diagnostics, operational efficiency, and strategic procurement.

Market Snapshot: Helicobacter pylori Non-Invasive Testing Market

The Helicobacter pylori non-invasive testing market is showing consistent growth, projected to expand from USD 1.19 billion in 2025 to USD 1.27 billion in 2026, reaching USD 1.88 billion by 2032 with a CAGR of 6.70%. This positive trajectory is driven by rising adoption of patient-centric diagnostic tools, laboratory operational advancements, and strategic procurement decision-making among healthcare stakeholders. Investment is focused on scalable, reliable workflows and innovative assay solutions that meet the evolving requirements of healthcare organizations.

Scope & Segmentation

This report provides a comprehensive analysis of the Helicobacter pylori non-invasive testing market, detailing critical segmentation areas and regional nuances that help stakeholders understand growth opportunities and operational risks. Market segmentation is designed to inform strategy development and resource allocation across operational environments.

  • Test Types: Includes Serology Tests (IGa, IGg, IGm), Stool Antigen Tests such as Monoclonal and Polyclonal Antibody Tests, and Urea Breath Tests, each supporting different diagnostic workflows and clinical settings.
  • Technologies: Covers Immunoassay techniques (Elisa, Rapid Immunoassay), Infrared Spectrometry, and advanced Mass Spectrometry methods (GC MS, LC MS), underlining the importance of analytical performance and automation.
  • End Users: Encompasses Clinics (Gastroenterology, Primary Care), Diagnostic Laboratories, and Hospitals (Secondary and Tertiary Care), each associated with unique operational demands and care pathways.
  • Distribution Channels: Addresses both Offline and Online channels, reflecting conventional purchasing alongside integration with digital and telehealth-enabled procurement workflows.
  • Regions: Focuses on the Americas, Europe, Middle East & Africa, and Asia-Pacific, each marked by distinct healthcare infrastructure, regulatory environments, and market access drivers.

Key Takeaways for Senior Leaders

  • Procurement strategies are being shaped by the need to balance clinical value with workflow efficiency and practical operational constraints.
  • Advances in assay chemistry and laboratory automation are streamlining sample management and contributing to improved diagnostic reliability and patient care.
  • Collaborative approaches between diagnostic firms and healthcare providers are being fostered by shifts in regulatory and reimbursement expectations toward evidence-backed and care-impactful solutions.
  • Supply chain management, with its focus on robust sourcing and inventory diversification, plays a pivotal role in risk mitigation around cost and reagent supply.
  • Effective product positioning hinges on tailored value messaging that aligns test features with the workflow and clinical demands of different end user profiles.
  • Bundled service models and strategic alliances are contributing to more integrated and flexible diagnostic offerings, redefining competitive benchmarks.

Impacts of Tariff Policy on Supply Chains

Recent updates in United States tariff policy have added new dimensions to supply chain and procurement management for Helicobacter pylori non-invasive testing solutions. Increased costs for imported reagents and equipment are leading laboratories and procurement teams to emphasize longer-term supplier relationships, enhanced regional sourcing, and the establishment of more resilient safety stock levels. Such adaptations influence operational spending and may drive preferences toward diagnostics with streamlined resource requirements or locally sourced components. Larger healthcare organizations with established procurement systems are generally more agile in responding to these challenges, while smaller entities may experience intensified cost pressure.

Segment Intelligence and Regional Nuances

Segment analysis demonstrates a strong correlation between operational settings and technology adoption. In the Americas, established laboratory networks and payer-policy alignment promote evidence-based procurement and rapid technology integration. The markets in Europe, Middle East & Africa are varied, with advanced sites quickly deploying new technologies, while resource-constrained providers prioritize durability and affordability. Asia-Pacific’s market is buoyed by infrastructure growth and a strong focus on screening programs, with localized production bolstering supply chain security. Vendors who align strategies with these specific regional operational drivers and regulatory climates are well positioned for adoption and differentiation.

Competitive Landscape and Strategic Moves

Competition in the Helicobacter pylori non-invasive testing market is advancing through enhancement of analytical performance, workflow integration, and comprehensive diagnostic-service bundling. Leading companies are deepening partnerships and leveraging real-world evidence to enhance reimbursement prospects and support clinical guideline adoption. Lab purchasers prioritize technical reliability, assured supply, and strong implementation support, favoring end-to-end diagnostic solutions that optimize analytics and clinical workflows across care settings.

Methodology & Data Sources

The insights in this report are based on a mixed-methods research approach combining interviews with clinical and laboratory leaders, rigorous reviews of clinical literature, regulatory documents, and guideline statements. Findings are validated through operational sensitivity analysis and rigorous cross-validation for reproducibility.

Why This Report Matters

  • Empowers senior leaders with integrated strategic, operational, and regional perspectives for confident decision-making.
  • Identifies emerging opportunities and operational risks linked to regulatory shifts and technological advancements.
  • Clarifies how segmentation and adoption patterns influence competitive positioning in a fast-evolving market.

Conclusion

Organizations that proactively address evolving clinical, operational, and regulatory shifts in Helicobacter pylori non-invasive testing are better equipped to enhance diagnostic efficiency, streamline workflows, and strengthen supply chain resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Helicobacter Pylori Non-invasive Testing Market, by Test Type
8.1. Serology Test
8.1.1. IGa Test
8.1.2. IGg Test
8.1.3. IGm Test
8.2. Stool Antigen Test
8.2.1. Monoclonal Antibody Test
8.2.2. Polyclonal Antibody Test
8.3. Urea Breath Test
9. Helicobacter Pylori Non-invasive Testing Market, by Technology
9.1. Immunoassay
9.1.1. Elisa
9.1.2. Rapid Immunoassay
9.2. Infrared Spectrometry
9.3. Mass Spectrometry
9.3.1. Gc Ms
9.3.2. Lc Ms
10. Helicobacter Pylori Non-invasive Testing Market, by End User
10.1. Clinics
10.1.1. Gastroenterology Clinic
10.1.2. Primary Care Clinic
10.2. Diagnostic Laboratories
10.3. Hospitals
10.3.1. Secondary Care Hospital
10.3.2. Tertiary Care Hospital
11. Helicobacter Pylori Non-invasive Testing Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Helicobacter Pylori Non-invasive Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Helicobacter Pylori Non-invasive Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Helicobacter Pylori Non-invasive Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Helicobacter Pylori Non-invasive Testing Market
16. China Helicobacter Pylori Non-invasive Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. ACON Laboratories, Inc.
17.7. Bio-Rad Laboratories, Inc.
17.8. BIOHIT OYJ
17.9. Biomerica, Inc.
17.10. Boditech Med Inc.
17.11. CerTest Biotec S.L.
17.12. Medline Industries, Inc.
17.13. Meridian Bioscience Inc.
17.14. Metabolic Solutions, Inc.
17.15. Quidel Corporation
17.16. Sekisui Chemical Co., Ltd.
17.17. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGA TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGA TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGA TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGG TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGG TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGG TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGM TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGM TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IGM TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY UREA BREATH TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY UREA BREATH TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY UREA BREATH TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY INFRARED SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY INFRARED SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY INFRARED SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GC MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GC MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GC MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LC MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LC MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LC MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GASTROENTEROLOGY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GASTROENTEROLOGY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GASTROENTEROLOGY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY PRIMARY CARE CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY PRIMARY CARE CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY PRIMARY CARE CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SECONDARY CARE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SECONDARY CARE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SECONDARY CARE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 132. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 133. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 153. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 154. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 155. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 157. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 158. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 160. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 161. AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 177. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 178. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 180. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 181. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 183. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 184. ASEAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 187. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 188. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 189. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 191. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 192. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 194. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 195. GCC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 209. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 210. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 211. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 213. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 214. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 216. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 217. BRICS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 220. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 221. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 222. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 224. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 225. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 227. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 228. G7 HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 231. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 232. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 233. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 235. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 236. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 239. NATO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 254. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2032 (USD MILLION)
TABLE 255. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2032 (USD MILLION)
TABLE 256. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 258. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 259. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 261. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 262. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Helicobacter Pylori Non-invasive Testing market report include:
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • BIOHIT OYJ
  • Biomerica, Inc.
  • Boditech Med Inc.
  • CerTest Biotec S.L.
  • Medline Industries, Inc.
  • Meridian Bioscience Inc.
  • Metabolic Solutions, Inc.
  • Quidel Corporation
  • Sekisui Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.27 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.88 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032 - Product Image

Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Non-invasive Helicobacter Pylori Testing - Global Strategic Business Report - Product Image

Non-invasive Helicobacter Pylori Testing - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Helicobacter Pylori Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Helicobacter Pylori Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 172 Pages
  • Global
From
Helicobacter Pylori Diagnostics - Global Strategic Business Report - Product Image

Helicobacter Pylori Diagnostics - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From

About the Helicobacter Pylori Non Invasive Testing Market

Within the realm of infectious disease testing, Helicobacter pylori (H. pylori) non-invasive testing plays a crucial role in the detection of the bacterium H. pylori, which is known to cause various gastrointestinal conditions, including gastritis, ulcers, and certain types of stomach cancer. Non-invasive testing methods are particularly advantageous as they can be administered without the need for endoscopic procedures. These tests include urea breath tests, stool antigen tests, and serological tests that detect antibodies against H. pylori in the blood. The market for H. pylori non-invasive testing is comprised of various test products that cater to the needs of different healthcare settings, from hospitals to clinics and even home testing environments. The development of accurate and user-friendly test kits allows for timely diagnosis and treatment, which is crucial in managing H. pylori-related infections. Moreover, advancements in testing technology have led to the improvement of test sensitivity and specificity, making non-invasive tests a reliable alternative to invasive diagnostic methods. Some companies operating within the H. pylori non-invasive testing market include DiaSorin, Thermo Fisher Scientific, Meridian Bioscience, Bio-Rad Laboratories, and Abbott Laboratories. These companies offer a range of products designed to detect H. pylori infection with varying methods of analysis, contributing to advances in non-invasive diagnostics and expanding the options available for healthcare providers and their patients. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.